Prospective Register Study to Assess Eligibility for and Efficacy of Surgical Treatment in Patients With nEuRovascular Conflict
- Conditions
- Tic DouloureuxTrigeminal NeuralgiaFacial PainGlossopharyngeal NeuralgiaHemifacial SpasmNeurovascular Conflict
- Registration Number
- NCT07135024
- Lead Sponsor
- Gerrit A Schubert
- Brief Summary
The aim of the registry is a multicenter, prospective long-term data collection of patients suspected neurovascular conflict and referred for possible microvascular decompression (Jannetta procedure). The registry relies exclusively on routinely collected clinical data, which are gathered in a standardized and privacy-compliant manner as part of everyday clinical practice. By systematically compiling this information across multiple centers, valuable insights into the effectiveness, potential side effects, and long-term outcomes of this surgical treatment can be gained. The registry will serve as a foundation for future scientific analyses and is intended to help answer relevant research questions regarding the treatment of trigeminal neuralgia based on solid evidence.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 5001
- suspected neurovascular conflict
- signed consent for further use of routine clinical data as accepted by local regulations
- refusal of further use of routine clinical data
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Face specific pain relief after surgical treatment From enrolment to last follow-up 5 yrs after surgery Efficacy of microvascular decompression surgery, defined by the change in facial pain and pain interference as assessed by the patient using the Brief Pain Inventory-Facial (BPI-Facial), with numerical scores ranging from 0 to 10, where higher scores represent worse outcomes.
Pain relief after surgical treatment From enrolment to last follow-up 5 yrs after surgery Efficacy of microvascular decompression surgery, defined by the change in pain as assessed by the patient using the Visual Analog Scale (VAS) from 0 to 100 mm, with higher scores representing worse outcomes.
- Secondary Outcome Measures
Name Time Method Patient satisfaction 5yrs after index surgery Perceived benefit of surgery as determined by Patient global impression of change (PGIC) scores. The PGIC is a 7-point, patient-reported scale that captures an individual's overall perception of change in their condition. It ranges from "very much improved" to "very much worse," enabling patients to rate whether they feel their health has improved, remained the same, or declined.
Effect of surgical treatment on quality of life 5 years after index surgery Efficacy of microvascular decompression surgery as defined by change of Quality of Life Questionaire as measured by EQ-5D-5L. The EQ-5D-5L is a standardized, patient-reported outcome measure that assesses health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of severity, ranging from "no problems" to "extreme problems.
Surgical complications three months after index surgery any complications directly attributable to the surgical intervention
Need for additional treatment 5 years after index surgery rate of patients having to undergo additional surgery / intervention / medication after microvascular decompression
Trial Locations
- Locations (2)
Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University
🇩🇪Aachen, NRW, Germany
Dept. of Neurosurgery, Cantonal Hospital Aarau
🇨🇭Aarau, Aargau, Switzerland
Dept. of Neurosurgery, RWTH Aachen University Hospital, RWTH Aachen University🇩🇪Aachen, NRW, GermanyHans Clusmann, Univ.-Prof. Dr. med.Contact+49 241 8088481hclusmann@ukaachen.de